News, reviews and podcasts from annual scientific meetings and symposiums around the world.
ASCO 2022: Novel immunotherapy combination improved survival in patients with metastatic melanoma
Combination immunotherapy treatment with anti-PD-1 and anti-CTLA-4 checkpoint inhibitors has proven effective as a front-line option for many patients…